Insider Trading & Ownership - Nuechterlein Carole

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for Nuechterlein Carole
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2023-10-25
Purchase
2023-10-27
4:15 pm
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
10% Owner
7,933,601$0.7568$6,004,14914,992,741
(Indirect)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2024-06-27
Option Award
2024-06-28
4:08 pm
N/A
2034-06-27
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
60,000$060,000
(Direct)
View
2024-02-27
Disposition
2024-02-28
5:29 pm
2022-06-17
2031-06-17
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
15,000$04,411
(Direct)
View
2024-02-28
Option Award
2024-02-28
5:29 pm
N/A
2031-06-17
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
4,411$04,411
(Direct)
View
2023-07-20
Option Award
2023-07-21
4:10 pm
N/A
2033-07-20
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
20,000$020,000
(Direct)
View
2022-06-23
Option Award
2022-06-27
4:12 pm
N/A
2032-06-23
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
15,000$015,000
(Direct)
View
2022-06-02
Option Award
2022-06-06
4:01 pm
N/A
2032-06-02
Entrada Therapeutics Inc.TRDANuechterlein Carole
Director
11,918$011,918
(Direct)
View
2021-10-28
Option Award
2021-11-01
7:00 pm
N/A
2031-10-28
Entrada Therapeutics Inc.TRDANuechterlein Carole
Director
23,552$023,522
(Direct)
View
2021-06-17
Option Award
2021-06-17
5:09 pm
N/A
2031-06-17
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
15,000$015,000
(Direct)
View
2020-10-20
Conversion
2020-10-20
4:55 pm
N/A
N/A
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
3,092,340$03,092,340
(Indirect)
View

Ownership
2020-10-15
5:13 pm
N/A
N/A
Aligos Therapeutics Inc.ALGSNuechterlein Carole
Director
0$03,092,340
(Indirect)
View
2020-06-22
Option Award
2020-06-23
07:07 am
N/A
2030-06-21
Millendo Therapeutics Inc.MLNDNuechterlein Carole
Director
12,000$012,000
(Direct)
View